RCEL
AVITA Medical Inc

1,140
Mkt Cap
$118.92M
Volume
318,296.00
52W High
$11.25
52W Low
$3.22
PE Ratio
-2.15
RCEL Fundamentals
Price
$3.90
Prev Close
$3.46
Open
$3.47
50D MA
$3.57
Beta
1.35
Avg. Volume
199,989.09
EPS (Annual)
-$2.39
P/B
-17.84
Rev/Employee
$247,119.23
Loading...
Loading...
News
all
press releases
D. Boral Capital Issues Pessimistic Forecast for Avita Medical (NASDAQ:RCEL) Stock Price
D. Boral Capital reduced their target price on shares of Avita Medical from $14.00 to $10.00 and set a "buy" rating on the stock in a research note on Thursday...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Avita Medical Inc. (NASDAQ:RCEL) Receives Average Rating of "Hold" from Analysts
Avita Medical Inc. (NASDAQ:RCEL - Get Free Report) has received an average recommendation of "Hold" from the five ratings firms that are currently covering the firm, Marketbeat.com reports. One...
MarketBeat·14d ago
News Placeholder
Avita Medical (NASDAQ:RCEL) Trading Up 0.6% - Here's What Happened
Avita Medical (NASDAQ:RCEL) Trading 0.6% Higher - What's Next...
MarketBeat·17d ago
News Placeholder
Avita Medical Inc. (NASDAQ:RCEL) Given Consensus Recommendation of "Hold" by Analysts
Avita Medical Inc. (NASDAQ:RCEL - Get Free Report) has earned an average recommendation of "Hold" from the six brokerages that are currently covering the stock, Marketbeat Ratings reports. Two...
MarketBeat·1mo ago
News Placeholder
Brokers Offer Predictions for Avita Medical FY2025 Earnings
Avita Medical Inc. (NASDAQ:RCEL - Free Report) - Investment analysts at Cantor Fitzgerald lowered their FY2025 EPS estimates for Avita Medical in a research note issued on Monday, November 10th...
MarketBeat·2mo ago
News Placeholder
Avita Medical (NASDAQ:RCEL) Issues Earnings Results
Avita Medical (NASDAQ:RCEL - Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.46) EPS for the quarter, missing the consensus estimate of ($0.43) by ($0.03...
MarketBeat·2mo ago
News Placeholder
Avita Medical's (RCEL) "Buy" Rating Reaffirmed at D. Boral Capital
D. Boral Capital restated a "buy" rating and set a $14.00 price target on shares of Avita Medical in a research note on Friday...
MarketBeat·2mo ago
News Placeholder
AVITA Medical (RCEL) Q3 2025 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·2mo ago
News Placeholder
New Strong Sell Stocks for Oct. 31st
FLWS, BLIN and RCEL have been added to the Zacks Rank #5 (Strong Sell) List on October 31, 2025.
Zacks·3mo ago
News Placeholder
Rosen Law Firm Encourages AVITA Medical, Inc. Investors to Inquire About Securities Class Action Investigation RCEL
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of AVITA Medical, Inc. (NASDAQ: RCEL) resulting from...
Business Wire·3mo ago
<
1
2
...
>

Latest RCEL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.